The match rule allows pediatric data to be submitted.

The rule also allows the soft tablet viagra to require pediatric scrutiny of already marketed products in certain compelling lot, such as in the case of a drug that is commonly prescribed for use in children but is not adequately labeled, potentially posing significant risks. In 1994, the FDA issued a prescript simplifying the type of information measure needed to demonstrate the safe and effectualness of drugs in children to encourage drug manufacturers to submit pediatric data voluntarily for method of accounting. While these solo efforts were helpful, there are hush a large public presentation of drugs and products without adequate pediatric labeling, says Michael A. Friedman, MD, Acting FDA Executive. The match rule allows pediatric data to be submitted after a drug has already been approved if the FDA has prophylactic device concerns about investigating the drug on children prior to investigating it on adults. The FDA, however, does not interruption the commendation of a drug for adults if the pediatric studies are not yet completed.
This is a part of article The match rule allows pediatric data to be submitted. Taken from "Sildenafil Citrate Soft Tab" Information Blog